Canadian Pacific Railway Limited (NYSE: CP) is expected to generate $ 1.58 billion in revenue for the quarter
Analysts expect Canadian Pacific Railway Limited (NYSE: CP) (TSE: CP) to announce revenue of $ 1.58 billion for the current fiscal quarter, reports Zacks Investment Research. Five analysts have estimated the Canadian Pacific Railway’s earnings to range between $ 1.57 billion and $ 1.62 billion. Canadian Pacific Railway had sales of $ 1.52 billion in the same quarter last year, which would represent a positive growth rate of 3.9% year over year. The company is expected to announce its next quarterly results on Tuesday, April 20th.
On average, analysts expect Canadian Pacific Railway to post total annual sales of $ 6.54 billion for the current fiscal year, with estimates ranging from $ 6.46 to $ 6.72 billion. For the next fiscal year, analysts expect sales of 6.98 billion US dollars, with estimates between 6.84 and 7.27 billion US dollars. Zacks Investment Research’s average revenue is based on a survey of analysts working on the Canadian Pacific Railway.
The Canadian Pacific Railway (NYSE: CP) (TSE: CP) last released its results on Tuesday, January 26th. The transportation company reported earnings of $ 5.06 per share for the quarter, beating the consensus estimate of $ 5.02 by $ 0.04. The company had revenue of $ 2.01 billion for the quarter, compared to analyst estimates of $ 2.07 billion. The Canadian Pacific Railway had a net margin of 29.66% and a return on equity of 32.77%. The company’s quarterly sales declined 2.8% compared to the same quarter of the previous year. For the same quarter last year, the company posted earnings of $ 4.77 per share.
Revenue is projected to grow from $ 10 billion in 2018 to an estimated $ 97 billion in 2026, according to a new report from Fortune Business Insights.
And this company is using AI to create a unique self-service experience that has never been seen before.
It’s no wonder more and more investors are stepping in before this explodes.
A number of stock analysts recently rated CP shares. Desjardins upgraded the Canadian Pacific Railway from a “Hold” rating to a “Buy” rating in a report on Thursday, January 28th. Smith Barney Citigroup raised its target price for the Canadian Pacific Railway from $ 355.00 to $ 430.00 in a report on Monday, January 11th. Citigroup Inc. 3% Minimum Coupon Principal Protected Based by Russell raised its target price for the Canadian Pacific Railway from USD 355.00 to USD 430.00 in a report on Monday, January 11th. Scotiabank upgraded the Canadian Pacific Railway from “Sector Performance” to “Outperform” in a report on Thursday, Jan. 28. Finally, TD Securities raised its target price on Canadian Pacific Railway from $ 500.00 to $ 505.00 and rated the stock as a “Buy” in a report on Thursday, January 28th. One analyst has rated the stock with a sell rating, four with a hold rating, and sixteen with a buy rating. The Canadian Pacific Railway currently has an average “Buy” rating and an average price target of $ 390.81.
NYSE CP’s shares opened at $ 361.31 on Thursday. The Canadian Pacific Railway has a twelve month low of $ 173.26 and a twelve month high of $ 379.00. The company has a current rate of 0.60, a quick rate of 0.51, and a leverage ratio of 1.18. The company has a market cap of $ 48.16 billion, a value for money of 28.81, a PEG ratio of 2.60, and a beta of 0.93. The company has a 50-day moving average of $ 355.05 and a two-hundred-day moving average of $ 328.83.
The company recently announced a quarterly dividend, which will be paid on Monday, April 26th. Shareholders of record on Friday March 26th will receive a dividend of $ 0.7436 per share. The ex-dividend date of this dividend is Thursday, March 25th. This equates to a dividend of $ 2.97 on an annual basis and a yield of 0.82%. This is an increase over the Canadian Pacific Railway’s previous quarterly dividend of $ 0.72. The Canadian Pacific Railway’s payout ratio is currently 24.05%.
A number of institutional investors have recently changed their position in business. Prospera Financial Services Inc acquired a new stake in the Canadian Pacific Railway worth approximately $ 32,000 in the third quarter. Mirova bought a new stake in Canadian Pacific Railway shares worth approximately $ 33,000 in the third quarter. Perigon Wealth Management LLC acquired a new stake in the Canadian Pacific Railway worth approximately US $ 36,000 in the fourth quarter. Sowell Financial Services LLC increased its stake in Canadian Pacific Railway 643.8% in the fourth quarter. Sowell Financial Services LLC now owns 119 shares in the transportation company, valued at $ 41,000, after purchasing an additional 103 shares last quarter. Finally, Montag A & Associates Inc. acquired a new position in Canadian Pacific Railway shares for $ 50,000 in the fourth quarter. 69.29% of the shares are owned by hedge funds and other institutional investors.
Via the Canadian Pacific Railway
Canadian Pacific Railway Limited, together with its subsidiaries, owns and operates a transcontinental rail freight company in Canada and the United States. The company transports bulk goods such as grain, coal, potash, fertilizers and sulfur. and cargo freight such as energy, chemicals and plastics, metals, minerals, and consumer, automotive and forestry products.
Featured Article: Marijuana Stocks That Considerations
Get a free copy of the Zacks Research Report on the Canadian Pacific Railway (CP).
For more information on research offerings from Zacks Investment Research, please visit Zacks.com
This instant message alert was generated through narrative science technology and financial data from MarketBeat to give readers the fastest, most accurate coverage possible. This story has been reviewed by the editorial staff of MarketBeat prior to publication. Please send questions or comments about this story to [email protected]
7 stocks that may be the real solution to the coronavirus puzzle
October 2nd, 2020 may not count as a “Where were you when?” Moments. But when the news came that the President of the United States and First Lady tested positive for the novel coronavirus, it certainly felt like we were living in a historic moment (as if we weren’t already).
In the days that followed, several biotech and pharmaceutical companies made headlines. However, these weren’t the vaccine stocks investors remembered. These were companies leading the race for antiviral therapeutics.
And with a very well known proof of concept, therapeutics may have had their moment. It is far too early to tell whether these drugs really hold the answer. However, from the start of the pandemic, there was a feeling that therapeutics could be the ultimate solution for neutralizing the most serious effects of the novel coronavirus.
As is to be expected, there is no shortage of enterprise in the therapeutic discussion. In this special presentation we introduce seven companies that you should pay special attention to. If therapeutics are one step ahead of a vaccine, those stocks are likely to see strong upward movements.
Check out the “7 Stocks That May Be the Real Solution to the Coronavirus Puzzle”.